1. Pink Sheet
  2. >>Geography
  3. >>Asia
  4. >>South Korea

Korea Vows Additional Support To CEPI For Future Pandemic Response

Growing Concerns Over Rising COVID-19, Mpox Cases

 
• By Jung Won Shin

South Korea is set to provide an additional $18m in support to CEPI amid heighted global worries over mpox. The coalition's CEO and Korea's foreign minister met to discuss strengthened collaboration to prevent and respond to any future pandemics.

CEPI CEO Richard Hatchett and Korean Foreign Minister Tae-Yul Cho
CEPI 'Proud Of Close Relationship With Korea' • Source: Korea's Ministry Of Foreign Affairs

Amid rising global cases of COVID-19 and mpox, the South Korean government has vowed to contribute an additional $18m to the Coalition for Epidemic Preparedness Innovations (CEPI) to strengthen the global health system, as CEPI board members visited the country to discuss international cooperation to control the spread of infectious diseases.

The decision comes after the World Health Organization declared the mpox outbreak a "public health emergency of international concern" earlier...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from South Korea

Profit-Sharing AI Model Proposed To Boost Korean Drug R&D

 
• By Jung Won Shin

A differentiated profit-sharing model to accelerate the use of AI in drug development using clinical and patient data is being proposed in South Korea, but the idea faces multiple practical challenges

New Era Begins In Korea: Policy Predictions For Biopharma

 
• By Jung Won Shin

As South Korea's new president immediately gets to work on setting initial policies, essential drug supplies, R&D incentives and AI-driven digital healthcare are among the key topics in focus.

Korean Pharma Industry Proposes Policies As Election Nears

 
• By Jung Won Shin

As South Korea gears up for a snap presidential election, its biopharma industry proposes key desired policies to candidates, most of whom have not laid out detailed plans of their own for the sector.

DIA Korea: Medical Turmoil, Global Factors Blunt Korea’s Trial Edge

 
• By Jung Won Shin

DIA Korea hears how multiple domestic and global factors are affecting the environment for clinical trials in South Korea, and what actions may be taken to address this.

More from Asia